Therefore, we performed a multicentre double-blind randomized control trial (RCT) to evaluate the efficacy of cholecalciferol supplementation on serum hepcidin levels and CKD-MBD parameters among ESKD patients on maintenance haemodialysis (MHD). The gene discussed is HAMP; the disease is Marchiafava-Bignami disease.